Ask a Researcher

Duration: 1 hr 6 mins
Publication Date: 2023 | June

About the session

During this session, researchers in different stages of their careers will share their perspectives. The panel will cover various topics, including expectations from journal publishers, researchers’ interest and capacity in serving as editorial board members, and support they need to publish their research. The panel will describe the tools and methods researchers use to initiate the publishing process and the criteria they consider when choosing where to publish. The session will further delve into researchers' opinions on pre-prints and examine their thoughts on the feedback they receive during peer review. Additionally, the panel will discuss researchers’ involvement in editorial roles, including remuneration, peer-review requests, how early career researchers can participate in the publishing process, how researchers view participation in special issues or invited content, and researchers’ views on Open Access and Open Access mandates. Additionally, the panel will discuss researchers’ involvement in editorial roles including remuneration, peer-review requests, how early career researchers can participate in the publishing process, how researchers view participation in special issues or invited content, and researchers’ views on Open Access and Open Access mandates.Additionally, the panel will discuss researchers’ involvement in editorial roles including remuneration, peer-review requests, how early career researchers can participate in the publishing process, how researchers view participation in special issues or invited content, and researchers’ views on Open Access and Open Access mandates.

Collection

Ask The Experts

Speakers

Director Division of Rhinology, Allergy and Anterior Skull Base Surgery Otolaryngology, Head & Neck Surgery, College of Medicine, University of Cincinnati

Dr. Sedaghat’s clinical interests and practice are focused on diseases of the nose and paranasal sinuses, which includes both inflammatory diseases -such as allergic rhinitis and chronic rhinosinusitis (CRS) as well as tumors of the sinonasal cavity as well as the anterior skull base
Postdoctural Researcher, Department of Methodology and Statistics at Utrecht University in the Netherlands

My research touches on time series analysis and dynamical systems, causal modeling, graphical models, Bayesian statistics and computational modeling. The tools I develop are broadly applicable across different areas of (behavioural) science and I collaborate with researchers from diverse backgrounds, such as clinical psychology and psychiatry, biomedical research, linguistics and public policy. All of the code I develop is made accessible either through reproducibility archives or R packages.
Royal National ENT Hospital, London & Division of Immunity and Infection, University College London. Honorary Consultant Physician and Honorary Associate Professor

Assoc. Prof. Glenis Scadding’s research interests include rhinitis and its co-morbidities, including asthma and rhinosinusitis; aspirin hypersensitivity and sublingual immunotherapy. She is additionally EUFOREA Board Member and Lead for Rhinitis, Scientific Chief Editor for Rhinology Section, Frontiers in Allergy, Former Chair of the Trustees of Rhinology and Laryngology Research Fund, and Past President of the British Society for Allergy and Clinical Immunology
Senior Clinical Fellow in ENT, Royal National ENT & Eastman Dental Hospitals

Mr Alfonso Luca Pendolino is a senior clinical fellow in ENT at University College London Hospitals and a PhD student at University College London. His special interest is in Rhinology and Facial Plastics. His research activity is mainly focusing on olfactory dysfunction in chronic upper respiratory tract diseases, evaluation and measurement of nasal airflow, nasal surgery and vasculitis affecting the nose and sinuses.
Group Leader, Dept. of Chemistry and Applied Biosciences, ETH Zurich

Dr. Silina is a Swiss National Science Foundation (SNSF) PRIMA group leader at the Institute of Pharmaceutical Sciences (IPW) at the ETH Zurich. In 2022, Dr. Silina started her own laboratory at the IPW, where her ongoing research efforts aim to define the physiological role and mechanisms of development of tertiary lymphoid structure (TLS) in cancer, which could potentially be manipulated as a novel immunotherapeutic approach.